Globalization and blood safety

Area of Science:

• Public Health
• Epidemiology
• Transfusion Medicine

Background:

• Globalization increases cross-border transactions and technology diffusion, impacting various sectors including blood safety.
• Rapid travel can spread blood-borne pathogens quickly, posing risks before countermeasures can be implemented.
• Ecological factors can amplify pathogen spread once introduced into new environments.

Purpose of the Study:

• To analyze the multifaceted effects of globalization on blood safety and supply.
• To highlight the challenges posed by globalized trade, travel, and industry changes to blood safety protocols.
• To advocate for a shift from a zero-risk paradigm to an integrated process approach in transfusion medicine.

Main Methods:

• Review of existing literature on globalization's impact on public health and blood safety.
• Analysis of case studies such as SARS, West Nile virus (WNV), and variant Creutzfeldt-Jakob disease (vCJD).
• Examination of industry trends like plasma product rationalization and technology monopolization.

Main Results:

• Globalization facilitates rapid spread of infectious diseases through travel and trade.
• Industry consolidation and technology access issues present new challenges to blood product safety and availability.
• Donor deferral measures, while intended to mitigate risks, can paradoxically reduce the safest donor pool, impacting supply.

Conclusions:

• Globalization necessitates a re-evaluation of blood safety strategies, moving beyond a product-centric to a process-oriented approach.
• Effective management of transfusion medicine requires acknowledging and managing risks rather than solely aiming for elimination.
• An integrated understanding of transfusion medicine's basic needs is crucial for navigating globalization's challenges to blood safety and supply.